Finally! Be free from smoking

Debi wrote an intriguing post today on
Here’s a little taster
New Delhi-based Super Religare Laboratories will distribute Rosetta Genomics’ three microRNA-based cancer tests in India, Saudi Arabia, Qatar, and United Arab Emirates.

The agreement covers Rosetta Genomics’ miRview test line, including the miRview mets test to identify the primary tumor site in patients with cancer of unknown primary origin, the miRview squamous test for differentiating squamous from non-squamous small cell lung cancer, and the miRview meso test for differentiating mesothelioma from other carcinomas in the lung.

Read the rest of this post here